Rodríguez RY, Martínez GI

Language: Spanish
References: 0
Page: 36-45
PDF size: 91.82 Kb.

ABSTRACT

Introduction: Diabetes mellitus is a disease whose incidence and complications annually increase. Diabetic foot is one of the most fearful complications due to its characteristics and the vascular damage that occurs. The Heberprot-P^® is a novel and unique drug for the treatment of this complication. Timely and appropriate use is important for limb salvage.
Objective: To describe the characteristics of patients with non ischemic diabetic foot treated with Heberprot-P^®.
Methods: Retrospective, descriptive and observational study conducted in 151 patients with non-ischemic diabetic foot treated with Heberprot-P^® in "General Calixto García" hospital in 2013 and 2014. The collected variables were age, sex, location, side effects, injury characteristics and outcomes.
Results: We found that 49.6 % of patients were over 60 years of age, 59.6 % were men and 92 % who suffered from type 2 diabetes mellitus. The most frequent location was the toes (33.8 %). In the study group, 21.1 % had some adverse reaction, being chills the most frequent. The highest number of cases went to Wagner classification II (31.1 %) and III (32.4 %); the lesions healed in 84.1 % of patients whereas 2.6 % were amputated.
Conclusions: It was observed that type 2 diabetic men aged over 60 years were more likely to suffering the disease, to having few adverse reactions, to healing more frequently and to being less amputated.